Every Form 4 that Cyabra, Inc. (CYAB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CYAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYAB filings page.
Cyabra Chief Product Officer Yossef Daar increased his stake through a private placement on July 10, 2026. He purchased 53,650 common shares at $0.435 per share from the company and acquired Series A and Series B warrants, each series covering 53,650 shares with exercise prices of $0.45 and $0.50 per share. The warrants become exercisable only after requisite stockholder approval. Following these transactions, Daar directly holds 894,199 common shares and the newly purchased warrants, which expire twelve months and five years, respectively, after their initial exercise dates.
CYABRA, INC. director James Francis Flanagan increased his exposure on July 10, 2026. He acquired 114,940 shares of common stock at $0.435 per share in a private placement, bringing his direct common stock holdings to 224,940 shares. He also purchased two series of common stock warrants, each covering 114,940 shares, with exercise prices of $0.50 and $0.45 per share. These warrants were bought in the same private placement and will become exercisable only after requisite stockholder approval, with one series expiring 12 months and the other five years after the initial exercise date.
Cyabra, Inc. Chief Technology Officer Shraga Ido purchased 53,650 shares of common stock from the company in a private placement at $0.435 per share, bringing his direct holdings to 894,199 shares.
He also acquired Series A and Series B warrants, each to purchase up to 53,650 common shares, with exercise prices of $0.45 and $0.50 per share. These warrants become exercisable only after requisite stockholder approval; the Series B warrants expire 12 months and the Series A warrants five years after their initial exercise dates.
CYABRA, INC. Chief Executive Officer Dan Brahmy purchased 53,650 shares of Common Stock from the company on July 10, 2026, in a private placement at $0.435 per share, bringing his direct holdings to 853,052 common shares. He also bought Series A and Series B warrants, each covering 53,650 Common Stock shares at $0.45 and $0.50 per underlying share, respectively; both warrant series become exercisable upon receipt of requisite stockholder approval, with the Series B Warrants expiring 12 months and the Series A Warrants five years after their initial exercise dates.
CYABRA, INC. Chief Financial Officer Yael Sandler received an equity grant tied to company stock. On May 14, 2026, Sandler was awarded 40,000 restricted stock units under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU converts into one share of common stock, giving Sandler 40,000 shares of direct ownership reported after this compensation-related award.
Flanagan James Francis reported acquisition or exercise transactions in this Form 4 filing.
CYABRA, INC. director James Francis Flanagan received an equity award in the form of restricted stock units. On May 14, 2026, he was granted 110,000 RSUs under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, with each RSU representing one share of common stock.
The RSUs vest over three years through April 1, 2029, meaning the shares will be delivered gradually as service conditions are met. After this grant, Flanagan’s reported direct holdings from this award total 110,000 shares of common stock-equivalent.
Shraga Ido reported acquisition or exercise transactions in this Form 4 filing.
CYABRA, INC. reported that Chief Technology Officer Shraga Ido received an equity compensation grant of 130,000 restricted stock units (RSUs) of common stock on May 14, 2026 under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan. The RSUs vest in quarterly installments of 26,000 shares of common stock through July 1, 2027, with each RSU representing one share. Following this grant, Ido holds 840,549 shares of common stock directly. The award was granted at a stated price of $0.0000 per share, reflecting a non-cash compensation grant rather than an open-market purchase.
CYABRA, INC. Chief Product Officer Yossef Daar received a grant of 130,000 restricted stock units of common stock as equity compensation. The grant was made at no cash cost per share and increases his directly held position to 840,549 common shares.
The RSUs were issued under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan and vest in quarterly installments of 26,000 shares of common stock through July 1, 2027. Each RSU converts into one share of common stock as it vests, aligning part of the executive’s compensation with future company performance.
Heymann Emmanuel reported acquisition or exercise transactions in this Form 4 filing.
CYABRA, INC. reported that Chief Revenue Officer Emmanuel Heymann received an equity award in the form of restricted stock units. On May 14, 2026, he was granted 100,000 RSUs under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, each representing one share of common stock. The RSUs vest over three years through April 1, 2029, aligning a portion of his compensation with the company’s longer-term performance and share price.
Madon Michael P reported acquisition or exercise transactions in this Form 4 filing.
Cyabra, Inc. director Michael P. Madon received an equity grant of 100,000 restricted stock units. The RSUs were awarded on May 14, 2026 under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan and carry a grant price of $0.00 per share.
The award vests over three years through April 1, 2029, with each RSU representing the right to receive one share of common stock. Following this grant, Madon holds 100,000 shares or RSUs directly, reflecting compensation rather than an open-market purchase or sale.
Brahmy Dan reported acquisition or exercise transactions in this Form 4 filing.
CYABRA, INC. director and Chief Executive Officer Dan Brahmy received a grant of 130,000 shares of common stock on a restricted stock unit basis as equity compensation. The award was recorded at a grant price of $0.00 per share and increased his directly held common stock to 799,402 shares.
The 130,000 restricted stock units vest in quarterly installments of 26,000 shares through July 1, 2027 under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan. Each RSU represents the right to receive one share of common stock with a par value of $0.0001.
Vu Sonny reported acquisition or exercise transactions in this Form 4 filing.
CYABRA, INC. director Sonny Vu reported an equity compensation grant and updated holdings. On May 14, 2026, he was granted 80,000 restricted stock units (RSUs) under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan. These RSUs vest over three years through April 1, 2029, with each RSU representing one share of common stock.
Following the grant, Vu holds 107,329 shares of common stock directly. An additional 273,278 shares are reported as held indirectly by FF Alabaster LLC, a related entity noted in the footnotes.
CYABRA, INC. Chief Product Officer Yossef Daar indirectly acquired common stock in connection with the company’s business combination and a new equity award. At the effective time of the Business Combination, 160,000 ordinary shares of Cyabra held for him were converted into 577,549 shares of the issuer’s common stock, held by IBI Trust Management in trust.
On March 27, 2026, he was also granted 133,000 restricted stock units under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, fully vested upon grant and effective 30 days after the 2026 Israeli Sub-Plan is filed with the Israel Tax Authority. Following these acquisitions, his indirect holdings reported in this filing total 710,549 shares.
CYABRA, INC. Chief Revenue Officer Emmanuel Heymann received two stock option awards tied to the company’s recent business combination. He was granted options over 25,264 shares of common stock at a $1.00 exercise price and options over 28,883 shares at a $7.53 exercise price, both expiring on February 19, 2033.
These options replace prior Cyabra Strategy Ltd. options under the Cyabra, Inc. 2026 Omnibus Incentive Plan. The January 2023 Replacement Option and January 2025 Replacement Option each vest over three years and ten months, with 25% vesting 10 months after their respective January 1 vesting commencement dates and the remainder vesting in equal monthly installments.
CYABRA, INC. director Michael P. Madon received a fully vested stock option grant tied to the company’s recent business combination. The award covers options to buy 14,436 shares of common stock at an exercise price of $1.00 per share, expiring on January 8, 2035.
According to the footnotes, this option replaces a prior Cyabra Strategy Ltd. option for 4,000 ordinary shares under the merger agreement with Trailblazer Merger Corporation I. After this grant, Madon holds options covering 14,436 shares, reflecting compensation and equity alignment following the transaction.